Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on July 6, 2026

Jul. 6, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Indeterminate GlobeNewswire

Jul. 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Indeterminate GlobeNewswire

Jul. 6, 2026

Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine

Indeterminate GlobeNewswire

Jul. 6, 2026

Alberta Cancer Foundation invests $35-million to power cancer clinical trials for Albertans

Indeterminate GlobeNewswire

Jul. 6, 2026

Clareo Plastic Surgery Named Best Plastic Surgery Practice in Boston

Indeterminate GlobeNewswire

Jul. 6, 2026

MESA LABS DECLARES QUARTERLY DIVIDEND

Indeterminate GlobeNewswire

Jul. 6, 2026

Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

Cannabix Technologies Announces Detection of Cocaine and Benzoylecgonine in Human Breath

Indeterminate GlobeNewswire

Jul. 6, 2026

Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

Indeterminate GlobeNewswire

Jul. 6, 2026

LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD

Indeterminate GlobeNewswire

Jul. 6, 2026

Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting

Indeterminate GlobeNewswire

Jul. 6, 2026

LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia

Indeterminate GlobeNewswire

Jul. 6, 2026

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

Indeterminate GlobeNewswire